News

Investor's Business Daily on MSN2d
Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
MMJ International Holdings: MMJ International Redefines Medical Cannabis with First Plant-Based Drug for a Rare Neurological Disease
MMJ-001 Marks a Pharmaceutical First in Cannabis Medicine with FDA-Grade Formulation for a Devastating Neurological Disorder while awaiting final FDA approval for use in clinical trials.